Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Abbott researchers describe new protein kinase inhibitors, their preparation and use

Nov. 7, 2003

New antitumor compounds identified at Welichem

Nov. 7, 2003

Eisai patent covers new hemiasterlin analogues for cancer therapy

Nov. 7, 2003

YM BioSciences cleared to begin pivotal trial of tesmilifene

Nov. 6, 2003

Ark Therapeutics granted patent for EG-009

Nov. 6, 2003

Novartis scientists identify new steryl-sulfatase inhibitors

Nov. 6, 2003

New KDR/Tie-2 kinase inhibitors in early development at Abbott

Nov. 6, 2003

Merck subsidiary seeks approval for Erbitux in Australia

Nov. 5, 2003

Merck presents new KSP inhibitors with utility in cancer therapy

Nov. 5, 2003

Potent Tie-2 inhibitors discovered to be effective in models of angiogenesis

Nov. 4, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...